About Sinopharm India Private Limited
Data last updated:
Sinopharm India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Sinopharm International Hongkong Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2012FTC245919. Its GSTIN is 07AASCS3650F1Z4 (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹4.8 Cr and a paid-up capital of ₹4.8 Cr. It is led by directors Rajesh Singh Rathore and Liao Chuankun.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 403 – 404 A 4th Floor Southern Park Saket District Centre, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.82 Cr, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹47.63 Lakh (net margin -26.2%) and EBITDA of -₹47.55 Lakh (EBITDA margin -26.2%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 44% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sinopharm. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sinopharm.com.
Company details
Contact details
Sinopharm India Private Limited's registered office is in New Delhi, Delhi. Its website is sinopharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 403 – 404 A 4th Floor Southern Park Saket District Centre, New Delhi, Delhi, India – 110017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sinopharm India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sinopharm India operates one associated brand: Sinopharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Vaccines for infectious diseases including EV71 and COVID-19 are developed. | sinopharm.com |
Business activity
The main business activities of Sinopharm India are trade and professional, scientific and technical. In detail, this covers wholesale trading and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Sinopharm India Private Limited, buy the company report.
Financials of Sinopharm India Private Limited
FY 2024 filings availableSinopharm India Private Limited reported revenue of ₹1.82 Cr (down 66% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 44% over five years, including a 66% fall in the latest year. EBITDA fell 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.82 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹47.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹47.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -26.2% | ||||
| Net Profit Margin | -26.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sinopharm India Private Limited, buy the company report.
Board of directors of Sinopharm India Private Limited
Sinopharm India has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Singh Rathore | Director | 06 Apr 2021 | 5 Years 6 Months | Current |
| Liao Chuankun | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
Peer comparison
Sinopharm India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medreich Life Care Limited | ₹1.83 Cr (FY 2022) | -47.0% | Bangalore, Karnataka, India | |||
| Acurela Pharms Limited | ₹1.83 Cr (FY 2025) | 54.0% | Bangalore, Karnataka, India | |||
| Jak Pharmalab Private Limited | ₹1.82 Cr (FY 2024) | -31.0% | Mumbai, Maharashtra, India | |||
| Carneo Pharma (OPC) Private Limited | ₹1.82 Cr (FY 2025) | 214.0% | Pune, Maharashtra, India | |||
| SM Traders Private Limited | ₹1.82 Cr (FY 2025) | 68.0% | Ernakulam, Kerala, India | |||
| Sinopharm India Private Limitedthis company | ₹1.82 Cr (FY 2024) | -₹47.63 Lakh | -26.2% | -66.0% | 7 | New Delhi, Delhi, India |
| Uvb Healthcare Private Limited | ₹1.8 Cr (FY 2024) | -77.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sinopharm India Private Limited, buy the company report.
Auditor
Sinopharm India Private Limited is audited by Dewan P.N. Chopra & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Dewan P.N. Chopra & Co. | FY 2024 | 000472N |
Shareholding
The shareholding of Sinopharm India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sinopharm India Private Limited, buy the company report.
Legal cases
Sinopharm India Private Limited has 4 court cases on record: 1 filed by Sinopharm India, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, HARYANA | Criminal miscellaneous application | Filed by the company against State of Haryana and 1 other | Pending |
| District court, Gurugram, Haryana | Commercial suit | Filed against the company by State of Haryana Through App | Pending |
| District court, Gurugram, Haryana | Court case (CRR) | Filed against the company by State of Haryana | Disposed |
| District court, Ambala, Haryana | Court case (COMI) | Filed against the company by Distt App. Authority | Disposed |
To see the full case history of Sinopharm India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sinopharm India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sinopharm India Private Limited has a workforce of 7 employees on its EPFO records as of Apr 09, 2025, across 1 active EPFO establishment.
GST
Sinopharm India has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCS3650F1Z4 | Delhi | Active | 01 Jul 2017 |
| 27AASCS3650F1Z2 | Maharashtra | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of Sinopharm India Private Limited, buy the company report.
Recent activity
Sinopharm India Private Limited has 8 board changes on record since 2012: 2 appointments and 6 cessations. The latest: Shi Hongwei ceased to be Director on 30 Sep 2022.
News
Frequently asked questions
Sinopharm India is an active foreign private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 December 2012 (14+ years old) and is registered under CIN U51397DL2012FTC245919.
Sinopharm India has 2 current directors:
- Rajesh Singh Rathore - Director
- Liao Chuankun - Director
The latest financial statements of Sinopharm India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sinopharm India is 07AASCS3650F1Z4, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AASCS3650F1Z2 (Maharashtra).
The CIN (Corporate Identification Number) of Sinopharm India is U51397DL2012FTC245919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sinopharm India has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Sinopharm India was incorporated on 10 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sinopharm India by revenue are Medreich Life Care Limited, Acurela Pharms Limited, Jak Pharmalab Private Limited, Carneo Pharma (OPC) Private Limited, SM Traders Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Shi Hongwei ceased to be Director on 30 Sep 2022. Rajesh Singh Rathore ceased to be Additional Director on 25 Oct 2021. Rajesh Singh Rathore was appointed as Director on 06 Apr 2021. Sinopharm India has 8 board changes on record in total.
Sinopharm India can be reached through the website sinopharm.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Sinopharm India is at Unit No. 403 – 404 A 4th Floor Southern Park Saket District Centre, New Delhi, Delhi, India – 110017.